Not applicableStudy completedNCT00343577What this trial is testingAntiproteinuric Agents and Fabry DiseaseWho this might be right forFabry DiseaseProteinuria University of Alabama at Birmingham 12
Not applicableLooking for participantsNCT05473637What this trial is testingTaiwan Associated Genetic and Nongenetic Small Vessel DiseaseWho this might be right forCerebral Small Vessel DiseasesCadasilHTRA1-Related Autosomal Dominant Cerebral Angiopathy+5 more National Taiwan University Hospital 500
Not applicableUnknownNCT05719337What this trial is testingMulti-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy AdultsWho this might be right forLeft Ventricular Hypertrophy First Hospital of China Medical University 660
Large-scale testing (Phase 3)Study completedNCT00074971What this trial is testingThe Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseWho this might be right forFabry Disease Genzyme, a Sanofi Company 58
Testing effectiveness (Phase 2)Ended earlyNCT03454893What this trial is testingOpen Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry DiseaseWho this might be right forFabry Disease AVROBIO 15
Early research (Phase 1)Study completedNCT02800070What this trial is testingAutologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry DiseaseWho this might be right forFabry Disease University Health Network, Toronto 5
Not applicableUnknownNCT04724083What this trial is testingInflammatory Pathways and Cardiac Growth Factors Associated With Fabry Disease CardiomyopathyWho this might be right forFabry Lysosomal and Rare Disorders Research and Treatment Center, Inc. 50
Not applicableActive Not RecruitingNCT07506083What this trial is testingNatural History in Fabry Disease With IVS4+919G>A MutationsWho this might be right forFabry Disease Chinese University of Hong Kong 31
Not applicableNot Yet RecruitingNCT07485660What this trial is testingCare Pathway for Patients With Fabry's Disease (Fabry-PATH)Who this might be right forFabry Disease University Hospital, Toulouse 200
Testing effectiveness (Phase 2)Looking for participantsNCT05629559What this trial is testing4D-310 in Adults With Fabry Disease and Cardiac InvolvementWho this might be right forFabry Disease 4D Molecular Therapeutics 18
Large-scale testing (Phase 3)Study completedNCT01218659What this trial is testingStudy to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry DiseaseWho this might be right forFabry Disease Amicus Therapeutics 68
Post-approval studies (Phase 4)Study completedNCT00081497What this trial is testingThe Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseWho this might be right forFabry Disease Genzyme, a Sanofi Company 67
Not applicableLooking for participantsNCT01581424What this trial is testingNatural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease StudyWho this might be right forFabry Disease University of Minnesota 50
Not applicableStudy completedNCT05671770What this trial is testingStudy Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)Who this might be right forFabry Disease Sanofi 15
Testing effectiveness (Phase 2)Looking for participantsNCT06858397What this trial is testingA proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry DiseaseWho this might be right forFabry Disesase GC Biopharma Corp 18
Not applicableEnded earlyNCT00149318What this trial is testingEnzyme Replacement Therapy in Fabry DiseaseWho this might be right forFabry Disease Mario Negri Institute for Pharmacological Research 2
Large-scale testing (Phase 3)Study completedNCT03614234What this trial is testingOpen Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease PatientsWho this might be right forFabry Disease Chiesi Farmaceutici S.p.A. 29
Very early researchLooking for participantsNCT06207552What this trial is testingEvaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry DiseaseWho this might be right forFabry Disease Children's Hospital of Fudan University 6
Testing effectiveness (Phase 2)Study completedNCT00196716What this trial is testingThe Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseWho this might be right forFabry Disease Genzyme, a Sanofi Company 21
Not applicableUnknownNCT01442350What this trial is testingMyocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of BiomarkersWho this might be right forFabry Disease, Cardiac VariantRight Ventricular Hypertrophy Francisco Marín Ortuño 120